Pfizer’s Paxlovid cooperation with CSPC Pharmaceutical Group is the latest in its expansion efforts in China.
CSPC, which earlier this year won approval from Chinese regulators for the country’s first locally developed mRNA Covid vaccine, will manufacture and sell the medication in mainland China, according to a Pfizer spokesperson. That coincided with a surge in demand for antivirals after Beijing’s abrupt dismantling of most Covid restrictions in late 2022 unleashed a virus wave that infected 80% of the population in less than two months.
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Applying science to TCM for natural pain reliefThe secrets of a centuries-old traditional Chinese medicine formulation are unlocked using scientific methods.
Source: staronline - 🏆 4. / 75 Read more »
Hong Kong exiles in UK say ‘living in fear’ of Beijing | The Malaysian InsightHong Kong exiles in UK say ‘living in fear’ of Beijing
Source: msianinsight - 🏆 8. / 63 Read more »
Chinese spy balloon used US tech to spy on AmericansAnalysis by defence agencies reveal the craft carried commercially available US gear.
Source: fmtoday - 🏆 5. / 72 Read more »
Chinese spy balloon did not gather data over US, says Pentagon | The Malaysian InsightChinese spy balloon did not gather data over US, says Pentagon
Source: msianinsight - 🏆 8. / 63 Read more »
Chinese spy balloon did not gather data over US: PentagonRyder said the US “took steps to mitigate” intelligence collection by the balloon. theSun thesundaily Chinese spyballoon Pentagon vitalintelligence
Source: theSundaily - 🏆 25. / 51 Read more »
Taiwan says 11 Chinese aircraft crossed median lineThis comes as Beijing ramps up military pressure on the democratic island.
Source: fmtoday - 🏆 5. / 72 Read more »